Healthcare Innovation

Read the highlights from our webinar exploring the impact of Medicare negotiation and what the first 10 drugs selected tell us about the program. Presented by Anna Kaltenboeck | ATI Advisory

ATI Advisory in partnership with the Rosalynn Carter Institute for Caregivers (RCI) sought to explore the evidence and needs of dementia caregivers that might inform a Medicare model test related to dementia care. On July 31, 2023, the Center for Medicare and Medicaid Innovation (CMMI) released the Guiding an Improved Dementia Experience (GUIDE) Model that includes explicit support for caregivers and is set to launch in July 2024.

Sarah Rosenblum and Allison Rizer explain how CAPABLE is a data-tested tool for dual eligible integration and pathways for state Medicaid programs to implement the program.

Anna Kaltenboeck writes for Health Affairs on the ways in which the Centers for Medicare and Medicaid Services can define and select drugs for the first round of prescription drug negotiations on September 1, 2023.

Medicare Advantage (MA) plans are able to offer additional benefits over the benefits all Medicare beneficiaries receive – called supplemental benefits. These supplemental benefits most typically take the form of vision, dental, hearing, and medical transportation services, but the types of benefits offered are evolving rapidly to include things like in-home support services or personal care, food, and help paying utility bills. Improving data available on these supplemental benefits in MA is clearly on the minds of officials at the Centers for Medicare and Medicaid Services (CMS).

Part 2 in the Health Affairs series co-authored by Allison Rizer focuses on policy opportunities for Medicare-Medicaid integration to benefit dual eligible individuals.